Abvc Biopharma ABVC Cash Flow Statement (2010-2026)

NASDAQ ABVC
$0.90 -0.04 (-4.26%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Sep2014 Dec2014 Sep2015 Dec2015 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-1.89M-6.90M-6.09M-1.95M-3.78M-4.33M-1.90M-2.32M-3.37M-0.70M-2.93M-1.05M-0.49M-0.80M-0.75M-2.33M-2.08M-3.02M-1.34M-0.64M
Depreciation and Depletion (Quarter)
0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.00M0.01M0.03M0.01M0.01M0.01M0.03M0.01M0.01M0.01M
Share-based Compensation (Quarter)
0.23M-0.02M4.69M0.23M0.23M-3.90M0.23M0.82M-0.51M1.94M0.28M0.10M1.62M0.05M1.57M1.14M3.43M0.07M0.51M
Deferred Taxes (Quarter)
0.13M0.57M-0.09M-0.08M0.14M0.90M-0.12M0.15M
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)
-0.41M1.42M0.18M0.19M0.21M-0.56M0.21M0.11M0.03M-0.33M
Cash from Operations (Quarter)
-2.22M-2.52M-2.99M-3.43M-0.51M-0.46M-1.50M-0.90M-1.36M-0.43M-0.96M-0.21M0.06M-0.70M-0.54M-0.89M-0.96M-0.59M-0.89M-0.24M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.10M0.10M0.10M-0.13M0.11M0.07M0.09M0.21M0.09M0.08M
Depreciation & Amortization (CF) (Quarter)
0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.00M0.01M0.03M0.01M0.01M0.01M0.03M0.01M0.01M0.01M
Change in Working Capital
Change in Receivables (Quarter)
0.03M-0.05M505.000.01M0.02M0.58M-0.11M-0.07M-0.01M-0.04M
Change in Inventory (Quarter)
-0.03M-0.00M64.00-0.00M0.01M
Change in Account Payables (Quarter)
-0.01M-0.02M0.06M0.02M-0.02M0.18M0.38M-0.03M-0.50M-0.03M0.13M0.02M0.09M
Change in Accured Expenses (Quarter)
-0.54M0.17M-0.04M0.02M-0.08M1.71M-0.15M0.68M0.12M-0.01M-0.04M0.13M-0.04M0.11M0.04M-0.02M-0.03M0.16M-0.01M0.05M
Change in Taxes (Quarter)
-0.02M0.01M-0.01M-0.01M
Other Working Capital Changes (Quarter)
-1.00-0.10M-0.10M-0.10M0.13M-0.11M-0.07M-0.10M-0.20M-0.08M-0.08M
Investing Activities
Change in Net Loans (Quarter)
-0.04M0.51M0.09M
Capital Expenditures (Quarter)
0.09M0.02M0.00M89.00-0.42M
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)
-0.81M0.43M-0.09M-0.02M-1.52M-0.08M-0.07M0.15M0.04M-0.51M-0.03M0.05M-0.10M
Financing Activities
Other financing activities (Quarter)
-0.02M0.39M-0.26M0.26M0.41M2.37M-1.79M0.32M-0.22M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
3.21M-0.03M-1.82M-1.54M0.22M-0.07M0.06M0.13M0.05M-0.09M0.05M0.49M-0.10M0.26M
Long-Term Debt Repayments (Quarter)
1.00M0.15M
Short-Term Debt issuances (Quarter)
1.00M0.03M0.03M0.03M0.03M0.03M0.66M0.03M
Short-Term Debt repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
1.28M0.76M2.59M0.26M0.26M
Net Equity Issued and Repurchased (Quarter)
4.24M0.25M-0.25M0.69M
Misc.
Cash from Financing Activities (Quarter)
5.82M4.25M0.60M-0.25M2.21M-0.03M1.66M0.04M0.92M0.80M-0.08M0.34M0.43M1.93M1.20M1.08M-0.34M0.23M
Exchange Rate Effect (Quarter)
0.00M-0.04M-0.05M-0.05M-0.20M0.22M-0.31M0.32M0.15M-0.17M-0.03M-0.01M0.00M0.00M0.01M-0.05M0.05M0.01M0.00M0.01M
Change in Cash (Quarter)
2.79M2.12M-3.13M0.17M-1.63M-0.58M0.40M-1.05M0.38M-0.40M-0.06M0.08M0.03M0.09M-0.10M0.32M-0.22M0.47M-1.19M-0.11M
Free Cash Flow (Quarter)
-2.22M-2.52M-3.09M-3.45M-0.52M-0.46M-1.50M-0.90M-0.94M-0.43M-0.96M-0.21M0.06M-0.70M-0.54M-0.89M-0.96M-0.59M-0.89M-0.24M
Net Cash Flow (Quarter)
2.79M2.16M-3.09M-3.45M-1.43M-0.80M0.71M-0.93M0.22M-0.24M-0.03M0.59M0.02M-0.37M-0.11M1.03M-0.27M0.46M-1.19M-0.12M